$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
用乐伐替尼治疗甲状腺癌的推荐剂量
2025-10-19 11:44:20
Check Details
分化型甲状腺癌吃乐伐替尼多久见效果?
2025-10-19 11:44:20
Check Details
乐伐替尼单药治疗分化型甲状腺癌情况
2025-10-19 11:44:20
Check Details
分化型甲状腺癌用乐伐替尼治疗可以有多久的生存期?
2025-10-19 11:44:20
Check Details
患者使用乐伐替尼的禁忌和注意事项
2025-10-19 11:44:20
Check Details
乐伐替尼医保可以报销吗?多少钱一盒?
2025-10-19 11:44:20
Check Details
塞尔帕替尼治疗晚期或转移性RET突变甲状腺癌情况
2025-10-19 11:44:20
Check Details
塞尔帕替尼纳入医保后的费用
2025-10-19 11:44:20
Check Details
RET靶向药塞尔帕替尼对甲状腺癌的效果和副作用
2025-10-19 11:44:20
Check Details
塞尔帕替尼在甲状腺癌中的应用
2025-10-19 11:44:20
Check Details
卡博替尼可用于治疗进展期、转移性的甲状腺髓样癌
2025-10-19 11:44:20
Check Details
卡博替尼治疗甲状腺髓样癌的效果好吗?
2025-10-19 11:44:20
Check Details
1
2
...
8582
8583
8584
8585
8586
8587
8588
...
10209
10210
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial
2
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide
3
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
4
Avatrombopag (Doptelet) Dosage: Dose Adjustment and Medication Guidelines for Different Indications
5
Effects of Gilteritinib (Xospata) Discontinuation in Acute Myeloid Leukemia Treatment
6
Avatrombopag vs Hetrombopag: Full Comparison of TPO Receptor Agonists for Thrombocytopenia
7
Deucravacitinib (Sotyktu): TYK2 Inhibitor Guide for Plaque Psoriasis Treatment
8
Biktarvy (Bictegravir/Emtricitabine/TAF) Dosing & Food Administration Guide
9
Valganciclovir (Valcyte) CMV Infection: Dosing Duration & Management Guide
10
Cabergoline Dosing Guide: Hyperprolactinemia & Prolactin Level Regulation
11
Rucaparib (Rubraca): Full FDA-Approved Guide for BRCA-Mutated Prostate Cancer Treatment
12
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment